AI assistant
TransMedics Group, Inc. — Director's Dealing 2019
May 7, 2019
31201_dirs_2019-05-06_416b96d7-e627-4d03-9fc4-3eeef4ab425b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2019-05-06
Reporting Person: Carey John F (VP of Operations)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-05-06 | Stock Option (Right to Buy) | $16.50 | J | 920 | Disposed | 2020-12-16 | Common Stock (262) | Direct |
| 2019-05-06 | Stock Option (Right to Buy) | $57.75 | J | 262 | Acquired | 2020-12-16 | Common Stock (262) | Direct |
| 2019-05-06 | Stock Option (Right to Buy) | $0.11 | J | 52130 | Disposed | 2021-09-27 | Common Stock (14894) | Direct |
| 2019-05-06 | Stock Option (Right to Buy) | $0.39 | J | 14894 | Acquired | 2021-09-27 | Common Stock (14894) | Direct |
| 2019-05-06 | Stock Option (Right to Buy) | $0.08 | J | 35000 | Disposed | 2023-03-27 | Common Stock (10000) | Direct |
| 2019-05-06 | Stock Option (Right to Buy) | $0.28 | J | 10000 | Acquired | 2023-03-27 | Common Stock (10000) | Direct |
| 2019-05-06 | Stock Option (Right to Buy) | $0.08 | J | 98514 | Disposed | 2023-05-29 | Common Stock (28146) | Direct |
| 2019-05-06 | Stock Option (Right to Buy) | $0.28 | J | 28146 | Acquired | 2023-05-29 | Common Stock (28146) | Direct |
| 2019-05-06 | Stock Option (Right to Buy) | $0.63 | J | 85530 | Disposed | 2027-06-22 | Common Stock (24437) | Direct |
| 2019-05-06 | Stock Option (Right to Buy) | $2.21 | J | 24437 | Acquired | 2027-06-22 | Common Stock (24437) | Direct |
Footnotes
F1: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the "Merger Agreement"), each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.
F2: The option is fully vested.
F3: The option vests as a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017.